source
- Alnylam inks up to $2 billion AI partnership with Inceptive Nucleics for RNAi drug discoveryAlnylam announced a three-year strategic collaboration with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The agreement is valued at up to $2 billion, with an initial $…
- Highmark Health sues HaloMD over alleged sham arbitration letter and misleading price dataHighmark Health, a Pennsylvania Blue Cross Blue Shield licensee with more than 7 million members, filed a complaint on June 1 in U.S. District Court in Western Pennsylvania accusing HaloMD of abusi…